Allergan plc (NYSE:AGN)

160.93
Delayed Data
As of Aug 22
 -0.32 / -0.20%
Today’s Change
114.27
Today|||52-Week Range
197.00
+20.40%
Year-to-Date
Endo Up on Settlement of a Few Cases Related to Opioid Drugs
Aug 21 / Zacks.com - Paid Partner Content
Implied Volatility Surging for Allergan (AGN) Stock Options
Aug 13 / Zacks.com - Paid Partner Content
Here's Why Allergan is Outperforming Its Industry Of Late
Aug 20 / Zacks.com - Paid Partner Content
Here's Why Amgen Stock is Outperforming Its Industry Of Late
Aug 13 / Zacks.com - Paid Partner Content
AbbVie's Latest FDA Approval Is Its Most Important Immunology Win Since Humira
Aug 20 / MotleyFool.com - Paid Partner Content
Can Value Investors Consider Allergan (AGN) a Worthy Pick?
Aug 13 / Zacks.com - Paid Partner Content
5 Top Cancer-Fighting Stocks to Buy Now
Aug 14 / MotleyFool.com - Paid Partner Content
3 Top Stocks With High Dividend Yields
Aug 11 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close161.25
Today’s open161.22
Day’s range160.20 - 161.50
Volume1,488,460
Average volume (3 months)4,129,970
Market cap$51.9B
Data as of 6:30pm ET, 08/22/2019

Growth & Valuation

Earnings growth (last year)-15.69%
Earnings growth (this year)+0.00%
Earnings growth (next 5 years)+4.95%
Revenue growth (last year)-0.96%
P/E ratioNM
Price/Sales2.85
Price/Book0.81

Competitors

 Today’s
change
Today’s
% change
TAKTakeda Pharmaceutica...+0.09+0.55%
VRTXVertex Pharmaceutica...-2.16-1.16%
ZTSZoetis Inc-1.00-0.78%
CELGCelgene+0.03+0.03%
Data as of 6:30pm ET, 08/22/2019

Financials

Next reporting dateOctober 30, 2019
EPS forecast (this quarter)$4.18
Annual revenue (last year)$15.8B
Annual profit (last year)-$5.1B
Net profit margin-32.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Executive Vice President-
Global Operations
Wayne R. Swanton
Corporate headquarters
Dublin, Dublin

Forecasts